Last reviewed: June 29, 2026
Last updated: June 29, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide and tirzepatide have transformed weight management for millions of people seeking sustainable fat loss, with clinical trials showing average weight reductions of 15–22 percent over one year. PlexusDx provides access to compounded versions of these medications from licensed 503A pharmacies, making precision weight loss therapy available nationwide without insurance hurdles. Understanding your options—injection versus oral, dosing pathways, and personalized genetic insights—helps you choose the right medication for your metabolic profile.
Understanding Semaglutide and Tirzepatide for Weight Loss
Semaglutide and tirzepatide are glucagon-like peptide-1 (GLP-1) receptor agonists that slow stomach emptying, increase feelings of fullness, and regulate appetite hormones in the brain. Semaglutide targets the GLP-1 receptor alone, while tirzepatide activates both GLP-1 and glucose-dependent insulinotropic peptide (GIP) receptors, making it a dual-action agent. Clinical data shows tirzepatide users experience weight loss up to 22 percent of body weight, compared to 15 percent with semaglutide, though individual results vary based on metabolism, genetics, and adherence.
Both medications work best when combined with lifestyle changes including nutritious eating patterns, regular movement, and adequate hydration. The choice between semaglutide and tirzepatide depends on your personal health history, genetic predispositions, and response to GLP-1 therapy. PlexusDx offers both injection and oral formulations, allowing you to select the delivery method that fits your daily routine and comfort level.
Comparing Injection vs Oral Formulations for GLP-1 Therapy
Compounded semaglutide and tirzepatide injections deliver medication subcutaneously once weekly, offering consistent blood levels and often faster symptom relief than oral versions. Injections bypass stomach acid and digestive enzymes, which means your body absorbs more active compound with smaller doses. PlexusDx compounded semaglutide injections start at $149 per month, while tirzepatide injections begin at $249 per month—flat pricing that never changes based on your dose escalation.
Oral formulations provide convenience for needle-averse patients and require daily dosing with fasting periods to maximize absorption. Oral semaglutide starts at $249 monthly, and oral tirzepatide at $279 monthly, also with flat monthly pricing regardless of strength. Neither injection nor oral is superior; your preference, needle comfort, and daily schedule should guide your selection. PlexusDx pharmacists help you weigh these factors during your initial consultation.
Accessing Compounded Medications Through Licensed Pharmacies
PlexusDx partners exclusively with licensed 503A compounding pharmacies, which are state-regulated facilities that create customized medications under strict quality controls and pharmacist oversight. These pharmacies source pharmaceutical-grade raw materials and compound each prescription individually, ensuring sterility and potency for injectable and oral formulations. Compounded medications allow for flexible dosing strengths and formulation adjustments that mass-manufactured products cannot provide, making them ideal for personalized weight loss protocols.
All PlexusDx medications are shipped directly to your home in all 50 states with no insurance requirement, membership fee, or prior authorization delays. Your medications arrive in discreet packaging with clear instructions, storage guidelines, and contact information for your dedicated PlexusDx clinical team. Payments are HSA and FSA eligible, reducing your out-of-pocket costs if you have a qualified health savings account.
Personalizing Your GLP-1 Protocol With Genetic Testing
PlexusDx Precision Peptide Genetic Test analyzes your DNA for variants in four key genes—GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—that influence how your body responds to GLP-1 and GIP receptor agonists. These genetic markers affect appetite regulation, metabolic rate, and medication effectiveness, allowing your clinician to predict whether you'll respond better to semaglutide, tirzepatide, or a dual-compound approach. The test maps 14 metabolic pathways and 150+ genetic insights into personalized recommendations, available for $99 after your first month of treatment.
Genetic testing removes guesswork from therapy selection and helps identify patients who may need higher doses, prefer oral over injection, or benefit from PlexusDx GLP-Squared dual compounds (semaglutide plus tirzepatide combined). Understanding your peptide-pathway genetics accelerates your weight loss timeline and reduces medication adjustments, ensuring you reach your goals faster and sustain your results long-term.
What to Expect During Your First Month on GLP-1 Therapy
Your initial dose begins low to allow your body to adapt to GLP-1 receptor signaling, typically starting with 0.25 mg semaglutide or 2.5 mg tirzepatide injected once weekly. Most patients experience reduced appetite and early weight loss within the first two weeks, though nausea, constipation, or mild stomach discomfort may occur as your digestive system adjusts. These side effects usually resolve within days to weeks as your body acclimate; your PlexusDx clinician monitors your response and adjusts your plan accordingly.
Your dose gradually increases over 4–12 weeks until you reach your therapeutic dose, the level where weight loss stabilizes and side effects remain manageable. Your dose may need to go up over time—your price won't, because PlexusDx charges a flat monthly rate regardless of strength. Weekly check-ins via secure messaging keep your clinical team informed of your progress, hunger levels, energy, and any concerns.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How do I get started with compounded semaglutide or tirzepatide at PlexusDx?
Complete your online health assessment, connect with a PlexusDx clinician via video or phone, and receive your personalized medication prescription within 24–48 hours. Your first shipment arrives within 3–5 business days with injection supplies, dosing instructions, and direct access to your clinical team via secure messaging.
Which is more effective for weight loss—semaglutide or tirzepatide?
Clinical trials show tirzepatide produces average weight loss of 20–22 percent of body weight versus 15–17 percent with semaglutide, because tirzepatide activates two hormone receptors instead of one. However, individual response depends on genetics, metabolism, and lifestyle; some patients achieve excellent results on semaglutide alone. PlexusDx Precision Peptide Genetic Test predicts which medication aligns better with your specific genetic profile.
Do I need insurance or a membership to use PlexusDx?
No. PlexusDx serves all 50 states with no insurance requirement, no membership fee, and no prior authorization delays. Compounded semaglutide starts at $149 monthly and tirzepatide at $249 monthly, with HSA and FSA eligibility to reduce your costs.
What are the common side effects of GLP-1 therapy?
Most patients experience mild nausea, constipation, or reduced appetite during the first 1–2 weeks, which typically resolve as your body adjusts. Serious side effects are rare but may include pancreatitis or severe allergic reactions; inform your PlexusDx clinician immediately if you develop severe abdominal pain, persistent vomiting, or difficulty breathing. Your clinical team monitors your health throughout treatment and adjusts your dose to minimize discomfort while maximizing weight loss.
How does PlexusDx Precision Peptide Genetic Test personalize my treatment?
The test identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R genes that predict your medication response, optimal dose range, and likelihood of success with semaglutide, tirzepatide, or dual compounds. Results map 150+ genetic insights across 14 metabolic pathways, enabling your clinician to recommend the exact protocol most likely to produce your best weight loss outcome.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Where Do You Inject the Ozempic Pen? A Comprehensive Guide
Navigating Safe Disposal: How Do I Dispose of an Ozempic Pen and Other Injectable Medications?